Kevin Buckman
See the following -
Viratech Announces Agreement For License Of Technology Platform For Cancer Patients
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for a license issued from Chris Ryan and Kevin Buckman for a patent-pending, provisional application titled "Method of Lowering a Cancer Patient's Morbidity Rate by Increasing Quality of Life of Patient by Leveraging Cause-Based Electronic Social Support Networks." Read More »
- Login to post comments
Viratech Corp. Publishes e-Book On Open Source Biotech Research
[Viratech Corp.] announced today that it has published its e-Book on open source biotech research. The book [...] describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. Read More »
- Login to post comments